CONMED
CNMD
290 hedge funds and large institutions have $2.47B invested in CONMED in 2024 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 111 increasing their positions, 108 reducing their positions, and 44 closing their positions.
3% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 108
0.16% more ownership
Funds ownership: 115.7% → 115.87% (+0.16%)
3% less funds holding
Funds holding: 298 → 290 (-8)
13% less capital invested
Capital invested by funds: $2.85B → $2.47B (-$379M)
16% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 44
47% less call options, than puts
Call options by funds: $4.18M | Put options by funds: $7.91M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$36.3M |
| 2 |
EARNEST Partners
Atlanta,
Georgia
|
+$32.6M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$22.5M |
| 4 |
DM
Deerfield Management
New York
|
+$21.4M |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
+$19.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$46.5M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$41.1M |
| 3 |
Jennison Associates
New York
|
-$24.9M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$11.8M |
| 5 |
Goldman Sachs
New York
|
-$10.7M |
CNMD Hedge Fund Activity: Q2 2024 in Review
290 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q2 2024, worth a combined $2.47B — down 13% from $2.85B a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of CNMD and 37 opened new positions — a net loss of 7 holders — while 108 trimmed existing stakes and 111 added.
The largest buyer was ArrowMark Colorado Holdings, opening a new position worth an estimated $36.3M. The largest seller was Magnetar Financial, exiting entirely with an estimated $46.5M sold.
- 290 institutional investors held CONMED (CNMD) as of Q2 2024, down from 298 in Q1 2024.
- Funds reported $2.47B of CONMED stock for Q2 2024, down 13% quarter-over-quarter.
- 37 funds opened new CONMED positions in Q2 2024 and 44 closed out, a net change of -7 holders.
- The largest CONMED buyer in Q2 2024 was ArrowMark Colorado Holdings, an estimated $36.3M added.
- The largest CONMED seller in Q2 2024 was Magnetar Financial, an estimated $46.5M sold.
Based on aggregated 13F filings for Q2 2024.